RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
复制标题
DOI:
10.1038/nature20558
复制
发表时间:
2016-12-01
期刊:
影响因子:
64.8
通讯作者:
Pasparakis M
中科院分区:
文献类型:
--
作者:
Lin J;Kumari S;Kim C;Van TM;Wachsmuth L;Polykratis A;Pasparakis M
Receptor interacting protein kinase 1 (RIPK1) regulates cell death and inflammation via kinase-dependent and -independent functions. RIPK1 kinase activity induces caspase-8-dependent apoptosis and RIPK3/Mixed Lineage Kinase Like (MLKL)-dependent necroptosis. In addition, RIPK1 inhibits apoptosis and necroptosis via kinase-independent functions, which are important for late embryonic development and the prevention of inflammation in epithelial barriers. The mechanism by which RIPK1 counteracts RIPK3/MLKL-mediated necroptosis has remained enigmatic. Here we show that RIPK1 prevents skin inflammation by inhibiting Z-DNA binding protein 1 (ZBP1, also named DAI or DLM1)-mediated activation of RIPK3/MLKL-dependent necroptosis. ZBP1 deficiency inhibited keratinocyte necroptosis and skin inflammation in mice with epidermis-specific RIPK1 knockout. Moreover, mutation of the conserved RIP Homotypic Interaction Motif (RHIM) of endogenous mouse RIPK1 (RIPK1mRHIM) caused perinatal lethality that was prevented by RIPK3, MLKL or ZBP1 deficiency. Furthermore, mice expressing only RIPK1mRHIM in keratinocytes developed skin inflammation that was abrogated by MLKL or ZBP1 deficiency. Mechanistically, ZBP1 interacted strongly with phosphorylated RIPK3 in cells expressing RIPK1mRHIM, suggesting that the RIPK1 RHIM prevents ZBP1 from binding and activating RIPK3. Collectively, these results showed that RIPK1 prevents perinatal death as well as skin inflammation in adult mice by inhibiting ZBP1-induced necroptosis. Furthermore, these findings identify ZBP1 as a critical mediator of inflammation beyond its previously known role in anti-viral defence and suggest that ZBP1 might be implicated in the pathogenesis of necroptosis-associated inflammatory diseases.
登录
查看更多内容
影响因子:
64.5
作者:
Rickard, James A.;O'Donnell, Joanne A.;Silke, John
通讯作者:
Silke, John
影响因子:
29.7
作者:
Chan FK;Luz NF;Moriwaki K
通讯作者:
Moriwaki K
DOI:
10.4049/jimmunol.181.9.6427
发表时间:
2008-11-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Kaiser WJ;Upton JW;Mocarski ES
通讯作者:
Mocarski ES
影响因子:
64.8
作者:
Dannappel M;Vlantis K;Kumari S;Polykratis A;Kim C;Wachsmuth L;Eftychi C;Lin J;Corona T;Hermance N;Zelic M;Kirsch P;Basic M;Bleich A;Kelliher M;Pasparakis M
通讯作者:
Pasparakis M
影响因子:
64.5
作者:
Cho YS;Challa S;Moquin D;Genga R;Ray TD;Guildford M;Chan FK
通讯作者:
Chan FK